How long does it take for Behcet s disease to develop into intestinal Behcet?

Intestinal Behcet's disease is a special type of Behcet's disease.

As long as Behcet's disease is diagnosed early, it is reasonable and effective to be carried out at an early stage, and it is completely possible to live.

Seventy, eighty, or even longer. This means that people with Behcet's disease have almost the same survival time as normal people, and the severity of Behcet's disease tends to decrease over time. Therefore, patients must establish confidence in overcoming the disease, actively cooperate, and adhere to follow-up and regular review of relevant indicators.

Behcet's disease is a type of systemic vasculitis, which is a chronic, autoimmune disease that can affect multiple systems and organs throughout the body. Patients with severe ophthalmia are often left with visual impairment or even blindness. If there is severe organ involvement, it can also be life-threatening.

So be sure to be regular**.

Some patients will be replaced with some diseases that are not common and not very good because of the body's immunity or living environment. Behcet's patients are a small part of this group of people who may have suicidal thoughts because they are discriminated against in society or because of the pain caused by physical diseases. So, what is the lifespan of the average Behcet's patient?

1. What is Behcet's disease?

Behcet's disease is a systemic disease of the immune system, also known as Behcet's syndrome, which is simply a type of vasculitis. Behcet's disease can cause damage to many organs in the body, including the mouth, ** and other organs. Patients may experience recurrent oral diseases, rashes, and intestinal ulcers.

The cause of Behcet's disease cannot be clearly defined by modern medicine, and it can only be preliminarily judged that the patient will suffer from Behcet's disease due to the influence of genetics and living environment. It is important to note that patients with Behcet's disease need to receive regular medications**, and if the patient discontinues**, the prognosis of the disease can be problematic or life-threatening. Therefore, after the disease, the patient must be active**.

2. What is the lifespan of a Behcet's patient?

In general, as long as the patient actively accepts ** after the diagnosis of the disease, the patient's life is not too threatened. If the patient's condition is properly controlled, the patient's life expectancy can be the same as that of a normal person. Therefore, patients do not need to panic after falling ill, and do not have the idea that they are suffering from a terminal illness and that there is no cure, and it is better to die, which is very abnormal and unhealthy.

Modern medicine mainly uses drugs to slow down Behcet's disease, but different patients need to take drugs for different periods of time, and most patients need to take drugs for a long time to control their condition. The drugs that Behcet's patients take when they receive ** are drugs that regulate the patient's immune system, including topical drugs and oral medications. If the condition of Behcet's patient Kevul is severe, surgery can also be performed**, but the ** rate is higher.

Intestinal Behcet's disease is the intestinal manifestation of Behcet's disease, which is mainly manifested as reverse-acting ulcers of the oral mucosa, nodular erythematous rash, subcutaneous thrombophlebitis and follicular rash. For intestinal Behcet's disease, activity should be restricted, adequate rest, and a liquid diet should be given, and after the condition improves, it can be changed to a nutrient-rich low-residue diet. Patients with severe abdominal pain and hematochezia should be absolutely quiet, supported by intravenous or enteral nutrition with rubber, and attention should be paid to correcting disturbances in water, electrolytes, and acid-base balance.

Patients with lead-poor jujube blood can be given blood transfusions. For patients with hypoproteinemia, human albumin can be appropriately supplemented. Antibiotics are not effective in general cases, and sensitive antimicrobials should be used in patients with severe secondary infections**.

Broad-spectrum combinations are used, as well as anti-anaerobic drugs such as metronidazole or ornidazole. At present, there is no specific drug for this disease, and the commonly used are aminosalicylic acid preparations, such as sulfasalazine, etc., as well as cytostatics, glucocorticoids, etc. For some patients, urgent surgery is also needed for treatment, such as intestinal perforation, obvious abdominal pain, abdominal percussion and mass, as well as deep ulcers, and patients who are ineffective through internal medicine conservative **.

Surgery should be done on a case-by-case basis, usually with ileocecal resection or right hemicolecal resection.

The pathological basis of Behcet's disease is vasculitis, a systemic disease that can often lead to chronic vascular inflammatory disease, and symptoms can also involve various systems of the body. When the gastrointestinal tract is affected, it is called intestinal Behcet's disease.

The most common manifestation of intestinal Behcet's disease is multiple ulcers of the gastrointestinal tract, which can occur from the mouth to the rectum. It usually involves the distal ileum, lower esophagus, stomach, ileocecal region, etc., with the ileocecal region being the most common, but also the nervous system, joints, and other parts.

Symptoms that cause the digestive tract usually include nausea and vomiting, but also abdominal pain, bloating, and bloody stools. If the ulcer is large and deep, it can cause bleeding and perforation in the digestive tract, and in severe cases, it is necessary to seek medical attention promptly.